ChemPartner PharmaTech Co Ltd Cash Flow-to-Debt Ratio
ChemPartner PharmaTech Co Ltd cash flow-to-debt ratio. ChemPartner PharmaTech Co Ltd (300149) has a Cash Flow-to-Debt Ratio of 0.03x as of June 2023, meaning its operating cash flow of CN¥28.21 Million could theoretically repay 0% of its total liabilities (CN¥1.06 Billion) in one year. Check how aggressively does ChemPartner PharmaTech Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ChemPartner PharmaTech Co Ltd (2007–2025)
Cash flow-to-debt ratio of ChemPartner PharmaTech Co Ltd from 2007 to 2025. Historical debt coverage capacity for ChemPartner PharmaTech Co Ltd across 19 annual periods. Check ChemPartner PharmaTech Co Ltd (300149) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
ChemPartner PharmaTech Co Ltd Cash Flow-to-Debt Ratio by Year (2007–2025)
ChemPartner PharmaTech Co Ltd cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for ChemPartner PharmaTech Co Ltd. For the full cash flow conversion analysis, see ChemPartner PharmaTech Co Ltd (300149) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | CN¥190.50 Million | CN¥732.59 Million | ▲ +17.1% |
| 2024 | 0.22x | CN¥168.21 Million | CN¥757.75 Million | ▲ +43.1% |
| 2023 | 0.16x | CN¥150.99 Million | CN¥973.44 Million | ▼ -15.0% |
| 2022 | 0.18x | CN¥262.46 Million | CN¥1.44 Billion | ▲ +7.5% |
| 2021 | 0.17x | CN¥378.22 Million | CN¥2.23 Billion | ▼ -17.4% |
| 2020 | 0.21x | CN¥343.16 Million | CN¥1.67 Billion | ▲ +40.0% |
| 2019 | 0.15x | CN¥215.07 Million | CN¥1.46 Billion | ▼ -31.0% |
| 2018 | 0.21x | CN¥243.19 Million | CN¥1.14 Billion | ▼ -30.3% |
| 2017 | 0.31x | CN¥63.43 Million | CN¥207.73 Million | ▼ -90.0% |
| 2016 | 3.07x | CN¥71.26 Million | CN¥23.23 Million | ▼ -1.9% |
| 2015 | 3.13x | CN¥100.69 Million | CN¥32.19 Million | ▲ +133.9% |
| 2014 | 1.34x | CN¥59.63 Million | CN¥44.60 Million | ▼ -2.7% |
| 2013 | 1.37x | CN¥46.32 Million | CN¥33.70 Million | ▼ -33.3% |
| 2012 | 2.06x | CN¥55.09 Million | CN¥26.72 Million | ▲ +295.4% |
| 2011 | 0.52x | CN¥11.66 Million | CN¥22.37 Million | ▼ -59.6% |
| 2010 | 1.29x | CN¥20.81 Million | CN¥16.12 Million | ▲ +240.5% |
| 2009 | 0.38x | CN¥13.28 Million | CN¥35.04 Million | ▼ -50.1% |
| 2008 | 0.76x | CN¥21.70 Million | CN¥28.57 Million | ▲ +49.0% |
| 2007 | 0.51x | CN¥22.19 Million | CN¥43.53 Million | — |